Paromomycin

Humatin

250 MG CapsuleCanadaMarketedAuthorised 31 Dec 1994

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Paromomycin

Humatin

250 MG CapsuleCanadaMarketedAuthorised 31 Dec 1994

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Saudi Arabia · Pfizer

Gabbroral Tab 250MGSaudi Arabia · Pfizer

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Paromomycin
Strength: 250 MG
Dosage form: Capsule
Route: Oral
Register: Canada (Health Canada)
Status: Marketed
Authorised: 31 Dec 1994
Registration: DIN 02078759
Marketing authorisation holder: Searchlight Pharma INC
ATC code: A07AA06
Group: Alimentary tract and metabolism
Supply: PRESCRIPTION